coronavirus and kids

The White House on Wednesday announced that they have enough Covid-19 vaccine to support 28 million children across the US as the rollout for those ages 5-11 nears.

Today the White House announced Wednesday kids 5-11 will soon be allowed to get a Covid-19 vaccine.

Preparing for the Covid-19 vaccine rollout for younger kids, how supply chain issues are causing problems for a landmark local deli, Connecticut towns still struggling with a school bus driver shortage and more on today’s episode of The Connection.

The FDA is now reviewing data from a COVID-19 vaccine trial in kids 5 to 11 years old, and there are already many questions about what this means for parents and our kids.

West Hartford Public schools will mandate masks for all students and staff this fall, according to a message from the superintendent.

While some parents are calling for an end to all mask requirements for kids in school, the Department of Public Health says it’s working on guidance for the return to class in the fall.

State officials are tracking the presence of the Delta strain of the COVID-19 virus. It’s a more dangerous strain of the virus and there’s questions about what it may mean for children under the age of 12 who can’t get vaccinated.  School has ended for almost all Connecticut children, but parents are already looking ahead to next year and...

Yale New Haven Children’s Hospital is launching a program to help children with long-term COVID-19 symptoms continue on the road to recovery.

Yale New Haven Health develops new program to help children suffering from long-haul COVID-19 challenges.

The US Food and Drug Administration expects to authorize the Pfizer vaccine for those age 12 to 15 by next week, potentially even sooner. At the same time, the company is looking at ways to make the vaccine available to children even younger.

More than 2,000 children ages 12-15 years old signed up for a COVID vaccine, joining Pfizer-BioNtech’s clinical trial in January.

A Yale doctor who is locally helping with Pfizer’s COVID-19 vaccine trials, says the early data on its use in children is very promising.